TMR의 조사 보고서 '세계의 생물학적 제제 시장'은 2025-2035년 예측 기간 동안 시장 지표에 대한 가치 있는 인사이트를 얻기 위해 과거 및 현재의 성장 동향과 기회를 연구합니다. 본 보고서는 2025년을 기준 연도, 2035년을 예측 연도로 설정하여 생물제제 세계 시장 수익과 예측을 제공합니다. 또한 2025-2035년 세계의 생물학적 제제 시장 연평균 성장률(CAGR%)도 제공합니다.
본 보고서는 광범위한 조사를 거쳐 작성되었습니다. 1차 조사에서는 KOL(Key Opinion Leader), 업계 리더, 의견 형성자들과 인터뷰를 실시했습니다. 2차 연구는 주요 업체들의 제품 문헌, 연차 보고서, 보도 자료 및 관련 문서를 참조하여 생물학적 제제 시장을 파악했습니다.
시장 현황
시장 매출(2024년)
4,488억 달러
시장 매출(2035년)
1조 1,402억 달러
CAGR
8.8%
본 보고서는 세계의 생물학적 제제 시장 경쟁 구도를 조사했습니다. 세계의 생물학적 제제 시장에서 활동하는 주요 업체들을 식별하고, 각 업체를 다양한 속성 측면에서 프로파일링했습니다. 기업 개요, 재무 현황, 최근 동향, SWOT 분석은 본 보고서에서 프로파일링된 세계의 생물학적 제제 시장 참여 기업 속성입니다.
목차
제1장 서문
제2장 전제조건과 조사 방법
제3장 주요 요약 : 세계 시장
제4장 시장 개요
소개
개요
시장 역학
세계의 생물학적 제제 시장 분석과 예측(2020-2035년)
제5장 주요 인사이트
주요 산업 이벤트
Porter's Five Forces 분석
PESTEL 분석
질병의 유병률과 발병률
파이프라인 분석
주요국 및 지역별 규제 시나리오
주요 국가 및 지역별 상환 시나리오
가격 동향
치료 알고리즘 및 옵션
최종 사용자 선호
제6장 세계 시장 분석과 예측 : 제품 유형별
소개 및 정의
주요 조사 결과 및 발전
시장 매출 예측 : 제품 유형별(2020-2035년)
단일클론항체
재조합 단백질
백신
세포 및 유전자 치료 제품
기타
시장 매력 분석 : 제품 유형별
제7장 세계 시장 분석과 예측 : 적응증별
소개 및 정의
주요 조사 결과 및 발전
시장 매출 예측 : 적응증별(2020-2035년)
종양학
자가면역질환 및 면역질환
혈액 질환
감염증
기타
시장 매력 분석 : 적응증별
제8장 세계 시장 분석과 예측 : 제조업별
소개 및 정의
주요 조사 결과 및 발전
시장 매출 예측 : 제조업별(2020-2035년)
아웃소싱
사내
시장 매력 분석 : 제조업별
제9장 세계 시장 분석과 예측 : 유통 채널별
소개 및 정의
주요 조사 결과 및 발전
시장 매출 예측 : 유통 채널별(2020-2035년)
소매 약국
병원 약국
온라인 약국
시장 매력 분석 : 유통 채널별
제10장 세계 시장 분석과 예측 : 지역별
주요 조사 결과
시장 매출 예측 : 지역별(2020-2035년)
북미
유럽
아시아태평양
라틴아메리카
중동 및 아프리카
시장의 매력 : 지역별
제11장 북미 시장 분석과 예측
제12장 유럽 시장 분석과 예측
제13장 아시아태평양 시장 분석과 예측
제14장 라틴아메리카 시장 분석과 예측
제15장 중동 및 아프리카 시장 분석과 예측
제16장 경쟁 구도
시장 기업 : 경쟁 매트릭스(기업 등급별, 규모별)
시장 점유율 분석 : 기업별(2024년)
기업 프로파일
AbbVie, Inc.
Amgen
AstraZeneca plc
Bristol-Myers Squibb Company
Eli Lilly & Company
Gilead Sciences, Inc.
GSK plc
Johnson & Johnson Services, Inc.
Merck & Co., Inc.
Novartis AG
Pfizer, Inc.
F. Hoffmann-La Roche AG
Regeneron Pharmaceuticals Inc.
HBR
영문 목차
영문목차
Biologics Market - Scope of Report
TMR's report on the global Biologics Market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the Market during the forecast period from 2025 to 2035. The report provides revenue of the global Biologics Market for the period 2025 to 2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global Biologics Market from 2025 to 2035.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the Biologics Market .
Market Snapshot
Market Value in 2024
US$ 448.8 Bn
Market Value in 2035
US$ 1140.2 Bn
CAGR
8.8%
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global Biologics Market .
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global Biologics Market. These serve as valuable tools for existing Market players as well as for entities interested in participating in the global Biologics Market .
The report delves into the competitive landscape of the global Biologics Market. Key players operating in the global Biologics Market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global Biologics Market profiled in this report.
Key Questions Answered in Global Biologics Market Report:
What are the opportunities in the global Biologics Market ?
What are the major drivers, restraints, opportunities, and threats in the Market ?
Which regional Market is set to expand at the fastest CAGR during the forecast period?
Which segment is expected to generate the highest revenue globally in 2035?
Which segment is projected to expand at the highest CAGR during the forecast period?
What are the Market positions of different companies operating in the global Market ?
Biologics Market - Research Objectives and Research Approach
The comprehensive report on the global Biologics Market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the Market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the Market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global Biologics Market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the Market share for each of these at the end of 2035 has been provided. Such valuable insights enable Market stakeholders in making informed business decisions for investment in the global Biologics Market.
Table of Contents
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Biologics Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Biologics Market Analysis and Forecast, 2020 to 2035
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Key Industry Events
5.2. Porter's Five Forces Analysis
5.3. PESTEL Analysis
5.4. Disease Prevalence & Incidence Rate
5.5. Pipeline Analysis
5.6. Regulatory Scenario by Key Countries/Regions
5.7. Reimbursement Scenario by Key Countries/Regions
5.8. Pricing Trends
5.9. Treatment Algorithm & Options
5.10. End-user Preference
6. Global Biologics Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product Type, 2020 to 2035
6.3.1. Monoclonal Antibodies
6.3.2. Recombinant Proteins
6.3.3. Vaccines
6.3.4. Cell & Gene Therapy Products
6.3.5. Others
6.4. Market Attractiveness Analysis, by Product Type
7. Global Biologics Market Analysis and Forecast, by Indication
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Indication, 2020 to 2035
7.3.1. Oncology
7.3.2. Autoimmune & Immunological Disorders
7.3.3. Hematological Disorders
7.3.4. Infectious Diseases
7.3.5. Others
7.4. Market Attractiveness Analysis, by Indication
8. Global Biologics Market Analysis and Forecast, by Manufacturing
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Manufacturing, 2020 to 2035
8.3.1. Outsourced
8.3.2. In-house
8.4. Market Attractiveness Analysis, by Manufacturing
9. Global Biologics Market Analysis and Forecast, by Distribution Channel
9.1. Introduction & Definition
9.2. Key Findings/Developments
9.3. Market Value Forecast, by Distribution Channel, 2020 to 2035
9.3.1. Retail Pharmacies
9.3.2. Hospital Pharmacies
9.3.3. Online Pharmacies
9.4. Market Attractiveness Analysis, by Distribution Channel
10. Global Biologics Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region, 2020 to 2035
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness By Region
11. North America Biologics Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product Type, 2020 to 2035
11.2.1. Monoclonal Antibodies
11.2.2. Recombinant Proteins
11.2.3. Vaccines
11.2.4. Cell & Gene Therapy Products
11.2.5. Others
11.3. Market Value Forecast, by Indication, 2020 to 2035
11.3.1. Oncology
11.3.2. Autoimmune & Immunological Disorders
11.3.3. Hematological Disorders
11.3.4. Infectious Diseases
11.3.5. Others
11.4. Market Value Forecast, by Manufacturing, 2020 to 2035
11.4.1. Outsourced
11.4.2. In-house
11.5. Market Value Forecast, by Distribution Channel, 2020 to 2035
11.5.1. Retail Pharmacies
11.5.2. Hospital Pharmacies
11.5.3. Online Pharmacies
11.6. Market Value Forecast, by Country, 2020 to 2035
11.6.1. U.S.
11.6.2. Canada
11.7. Market Attractiveness Analysis
11.7.1. By Product Type
11.7.2. By Indication
11.7.3. By Manufacturing
11.7.4. By Distribution Channel
11.7.5. By Country
12. Europe Biologics Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product Type, 2020 to 2035
12.2.1. Monoclonal Antibodies
12.2.2. Recombinant Proteins
12.2.3. Vaccines
12.2.4. Cell & Gene Therapy Products
12.2.5. Others
12.3. Market Value Forecast, by Indication, 2020 to 2035
12.3.1. Oncology
12.3.2. Autoimmune & Immunological Disorders
12.3.3. Hematological Disorders
12.3.4. Infectious Diseases
12.3.5. Others
12.4. Market Value Forecast, by Manufacturing, 2020 to 2035
12.4.1. Outsourced
12.4.2. In-house
12.5. Market Value Forecast, by Distribution Channel, 2020 to 2035
12.5.1. Retail Pharmacies
12.5.2. Hospital Pharmacies
12.5.3. Online Pharmacies
12.6. Market Value Forecast, by Country/Sub-region, 2020 to 2035
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Italy
12.6.5. Spain
12.6.6. Switzerland
12.6.7. The Netherlands
12.6.8. Rest of Europe
12.7. Market Attractiveness Analysis
12.7.1. By Product Type
12.7.2. By Indication
12.7.3. By Manufacturing
12.7.4. By Distribution Channel
12.7.5. By Country/Sub-region
13. Asia Pacific Biologics Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product Type, 2020 to 2035
13.2.1. Monoclonal Antibodies
13.2.2. Recombinant Proteins
13.2.3. Vaccines
13.2.4. Cell & Gene Therapy Products
13.2.5. Others
13.3. Market Value Forecast, by Indication, 2020 to 2035
13.3.1. Oncology
13.3.2. Autoimmune & Immunological Disorders
13.3.3. Hematological Disorders
13.3.4. Infectious Diseases
13.3.5. Others
13.4. Market Value Forecast, by Manufacturing, 2020 to 2035
13.4.1. Outsourced
13.4.2. In-house
13.5. Market Value Forecast, by Distribution Channel, 2020 to 2035
13.5.1. Retail Pharmacies
13.5.2. Hospital Pharmacies
13.5.3. Online Pharmacies
13.6. Market Value Forecast, by Country/Sub-region, 2020 to 2035
13.6.1. China
13.6.2. India
13.6.3. Japan
13.6.4. South Korea
13.6.5. Australia & New Zealand
13.6.6. Rest of Asia Pacific
13.7. Market Attractiveness Analysis
13.7.1. By Product Type
13.7.2. By Indication
13.7.3. By Manufacturing
13.7.4. By Distribution Channel
13.7.5. By Country/Sub-region
14. Latin America Biologics Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product Type, 2020 to 2035
14.2.1. Monoclonal Antibodies
14.2.2. Recombinant Proteins
14.2.3. Vaccines
14.2.4. Cell & Gene Therapy Products
14.2.5. Others
14.3. Market Value Forecast, by Indication, 2020 to 2035
14.3.1. Oncology
14.3.2. Autoimmune & Immunological Disorders
14.3.3. Hematological Disorders
14.3.4. Infectious Diseases
14.3.5. Others
14.4. Market Value Forecast, by Manufacturing, 2020 to 2035
14.4.1. Outsourced
14.4.2. In-house
14.5. Market Value Forecast, by Distribution Channel, 2020 to 2035
14.5.1. Retail Pharmacies
14.5.2. Hospital Pharmacies
14.5.3. Online Pharmacies
14.6. Market Value Forecast, by Country/Sub-region, 2020 to 2035
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Argentina
14.6.4. Rest of Latin America
14.7. Market Attractiveness Analysis
14.7.1. By Product Type
14.7.2. By Indication
14.7.3. By Manufacturing
14.7.4. By Distribution Channel
14.7.5. By Country/Sub-region
15. Middle East & Africa Biologics Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Product Type, 2020 to 2035
15.2.1. Monoclonal Antibodies
15.2.2. Recombinant Proteins
15.2.3. Vaccines
15.2.4. Cell & Gene Therapy Products
15.2.5. Others
15.3. Market Value Forecast, by Indication, 2020 to 2035
15.3.1. Oncology
15.3.2. Autoimmune & Immunological Disorders
15.3.3. Hematological Disorders
15.3.4. Infectious Diseases
15.3.5. Others
15.4. Market Value Forecast, by Manufacturing, 2020 to 2035
15.4.1. Outsourced
15.4.2. In-house
15.5. Market Value Forecast, by Distribution Channel, 2020 to 2035
15.5.1. Retail Pharmacies
15.5.2. Hospital Pharmacies
15.5.3. Online Pharmacies
15.6. Market Value Forecast, by Country/Sub-region, 2020 to 2035
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Market Attractiveness Analysis
15.7.1. By Product Type
15.7.2. By Indication
15.7.3. By Manufacturing
15.7.4. By Distribution Channel
15.7.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player - Competition Matrix (By Tier and Size of companies)
